Wieslab has the knowledge base that can make a difference to your study!
Wieslab Bioanalytical CRO service partner offers custom and kit-based services for quantifying cytokines, chemokines, and other biomarkers in animal or human matrices. Our scientists use ELISA, RIA or Electrochemiluminescence (ECL)-based assays to perform the biomarker work.
We perform in-house assay development and validation as well as use kits produced by other vendors. When applicable, we use kits from by our parent company Euro Diagnostica. We have experience with a broad range of cytokines and other biomarker assays using the assay system from Meso Scale Discovery (MSD).
Our bioanalytical CRO services are centered on large molecules (biologics and biosimilars) with a focus on immune-mediated diseases. We provide services for non-clinical as well as Phase I – III and post-marketing clinical studies for pharma, CRO and biotech clients.
Wieslab offers both clinical diagnostic testing as well as a wide range of bioanalytical services. The laboratory services are performed in an ISO 17025, GCP and GLP compliant environment ensuring that the regulatory requirements are met.
Wieslab – Your Bioanalytical CRO service partner
We offer method development/transfer, validation and samples analysis within our bioanalytical service areas:
- Method transfer – transfer and optimization of non-validated or validated assays to client specifications
- Method development – development of assays from scratch, or adaptation of any commercially available assay kit. We also offer optimisation services of customers assays
- Validation – validation of assays following relevant guidelines and white papers. Assays are always validated using a “fit for purpose” approach
- Sample analysis – from one plate, or a non-clinical study to Phase III clinical trial projects and post-marketing. Wieslab can handle variable sample numbers and large volumes to meet the needs of our clients.